Cosmica Biosciences ^Company

Cosmica Biosciences primarily engages in accelerating drug discovery for longevity. It utilizes unbiased multi-scale biology coupled with machine learning algorithms to develop precision-based interventions to extend the human lifespan on Earth and reduce health risks triggered by spaceflight exposures. Its platform leverages data generated from human blood and organoids exposed to microgravity simulation and galactic radiation and spaceflight, as well as in vivo data from commercial and non-commercial crew members and onboard experiments from NASA, SpaceX, and Axiom